Google has made some of the loudest buzz in the wearable space in 2026, launching new products, forming new partnerships, and adding new AI features. I’ve covered Oura, WHOOP, and Apple Watch extensively, but Google has remained uncovered by me.

In light of its recent partnership with Flo, I feel it’s now the right time to share Google’s wearable strategy.

In this article, I’ll highlight Google’s strategic timeline in the wearable and digital-health space, take a step back to highlight the greater trends in the wearable space, and offer my take on what this means for patients, physicians, and the health system.

Google has spent years building the components of a consumer-health platform. This year, it has started connecting them around a daily relationship with an AI health coach.

Below is a high-level timeline of Google’s foray into the wearable and digital health space. Understanding this timeline will help us see where Google might take its strategy in the future.

In 2026, the pieces are starting to come together. Google announced three linked changes:

This brought hardware, data aggregation, and paid coaching under one consumer-health experience.

In August, Google announced Health Guardian, which infers physiological trends based on data. This includes insulin-resistance trends, blood-pressure trends, sleep-breathing-quality trends, and a separate breathing-emergency-detection feature for eligible Pixel Watches. Do note that Google labels the trend features as general “wellness tools.” They do not provide real-time clinical readings, are not prescreeners for diabetes, hypertension, or sleep apnea, and should not guide medication changes. Remember the FDA drama with WHOOP?

Additionally, in August, Google and Abbott announced a multiyear partnership to integrate Lingo CGM data into Google Health and its coach. This will likely help Google touch up its insulin resistance trends algorithm based on real-time CGM data.

Now, in October, Google announced Fitbit Edge, expanded Health Guardian availability, and deeper integrations.

Google is assembling a more complete view of an individual by combining its own sensor data with information from specialized partners.

When I last covered the wearable space in June (Wearable Tech in 2026: What Every Physician Should Know), I highlighted AI coaching, lab testing, and the push into clinical care. Google’s latest moves follow that same direction: combining continuous wearable data with more context about the person wearing the device.

Sleep, activity, glucose, lab results, and reproductive health are increasingly coming together in one app, with AI helping users interpret the information. I think the competition will increasingly center on who can turn that broader picture into useful guidance—and connect users with a clinician when needed. The latter is the actionable insight.

This brings us closer to the “Guardian Angel Tech” I wrote about back in 2024: devices that recognize meaningful changes and help us intervene earlier.

Looking across Google’s Fitbit, WHOOP, Oura, and Garmin, I think the core offerings are starting to converge. Continuous tracking, recovery insights, and AI coaching are becoming expected features. Much like ambient scribes, parts of the wearable experience are becoming commoditized.

On the consumer side, I think differentiation will come from going deeper into the needs of a specific audience. WHOOP users have a phenotype. Garmin users have a phenotype. Someone focused on recovery may want more useful guidance on how to adjust their training. A cyclist may care more about clear, timely guidance on power output, thresholds, and pacing during a ride. Those details can matter more than adding another general-purpose AI feature.

Clinically, I see another opportunity: reliably identifying changes that warrant further evaluation.

The overlap between consumer and medical-grade wearables makes it harder to know which data we can act on. I recently saw a patient who was tachycardic in clinic and wearing an Apple Watch. Their heart-rate history suggested a normal rate before the visit, which gave me useful context. I still obtained an EKG to evaluate the tachycardia.

Sleep apnea offers another example. In a prospective study of 152 adults, researchers reported an AUROC of 0.94 for Samsung Galaxy Watch detection of moderate-to-severe obstructive sleep apnea compared with in-lab polysomnography. That’s a great AUROC, but a watch flag alone wouldn’t lead me to prescribe CPAP. I would still pursue diagnostic testing, such as a home sleep apnea test (with an FDA-approved medical device for OSA diagnosis) when appropriate.

For many of these features, the immediate clinical value is helping us decide who needs a closer look. A concerning trend can prompt a conversation, confirmatory measurements, or a formal workup, much like Apple Watch’s blood pressure notifications.

I think that could become an important differentiator: how reliably a wearable flags a potential problem and helps the user take the appropriate next step. For physicians, that means understanding how each feature was validated, who it was tested in, and what an alert should actually trigger.

In summary, Google is bringing wearables, health records, partner data, and AI coaching together into a more connected consumer-health platform. Its strategy reflects where the broader wearable space is heading, with companies competing to turn a fuller picture of our health into useful guidance. I think differentiation will increasingly come from serving specific audiences well and reliably flagging changes that warrant clinical evaluation. For physicians, the value will depend on how well those signals are validated and whether they help us make better decisions for patients.